Author

Jing-Mei Hsu

Observed name: Jing-mei Hsu

Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medicine

Observed institutions: State University of New York, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center

OpenAlex ID: A5113696013

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

2021 · Stephen J Schuster, Constantine S Tam, et al. · The Lancet Oncology · 585

The Yeast RSC Chromatin-Remodeling Complex Is Required for Kinetochore Function in Chromosome Segregation

2003 · Jing-mei Hsu, Jian Huang, et al. · Molecular and Cellular Biology · 111

Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT Outcomes

2020 · Christine Camacho-Bydume, Tao Wang, et al. · Transplantation and Cellular Therapy · 7

A Pilot Study of a Sequential Regimen of Intensive Chemotherapy (Bendamustine-Bridge) Followed by Autologous or Allogeneic Transplantation for Refractory Lymphomas

2017 · Tsiporah B. Shore, Yuliya Jhanwar, et al. · Transplantation and Cellular Therapy

Works count: 4

Citation count: 703

H-index: 3

I10-index: 2